Australia markets closed

Coloplast A/S (CBH.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
11.200.00 (0.00%)
At close: 08:08AM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 25.50B
Enterprise value 28.67B
Trailing P/E 37.28
Forward P/E 34.48
PEG ratio (5-yr expected) 3.20
Price/sales (ttm)7.25
Price/book (mrq)11.61
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.32
52-week change 3-8.20%
S&P500 52-week change 326.27%
52-week high 312.90
52-week low 39.25
50-day moving average 312.10
200-day moving average 310.75

Share statistics

Avg vol (3-month) 35
Avg vol (10-day) 3N/A
Shares outstanding 52.25B
Implied shares outstanding 62.28B
Float 8141.99M
% held by insiders 10.00%
% held by institutions 10.02%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.28
Forward annual dividend yield 42.47%
Trailing annual dividend rate 321.00
Trailing annual dividend yield 3187.50%
5-year average dividend yield 4N/A
Payout ratio 491.93%
Dividend date 3N/A
Ex-dividend date 417 May 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 30 Sept 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 19.45%
Operating margin (ttm)27.19%

Management effectiveness

Return on assets (ttm)10.51%
Return on equity (ttm)42.74%

Income statement

Revenue (ttm)25.53B
Revenue per share (ttm)11.52
Quarterly revenue growth (yoy)8.70%
Gross profit (ttm)N/A
EBITDA 7.83B
Net income avi to common (ttm)4.97B
Diluted EPS (ttm)0.30
Quarterly earnings growth (yoy)8.40%

Balance sheet

Total cash (mrq)889M
Total cash per share (mrq)3.95
Total debt (mrq)24.51B
Total debt/equity (mrq)151.29%
Current ratio (mrq)0.60
Book value per share (mrq)72.05

Cash flow statement

Operating cash flow (ttm)2.28B
Levered free cash flow (ttm)3.4B